<< Back To Home

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

Tuesday, 16th of May 2017 Print

 

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

Now that we have 30 years’ experience with hep B vaccination from the early adopters, including China, we are beginning to quantify the long term benefits. There are still policy issues: the birth dose, which is not yet universal in much of the world, and hep B vaccination of high risk groups, especially physicians and nurses.

Full text is at https://wwwnc.cdc.gov/eid/article/23/5/16-1477_article

40920015